78 of 138 ( 565 % , 95 % CI 478-649 ) patients who received sequential treatment had a pathological complete response in the breast versus 77 of 142 ( 542 % , 95 % CI 457-626 ) who received concurrent treatment ( difference 23 % , 95 % CI -93 to 139 ) .